Linezolid for patients with neutropenia: are bacteriostatic agents appropriate? - sprookjes - yvandenbroek - TriplyDB

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

http://www.wikidata.org/entity/Q37463209

about

Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer The challenge of antibiotic resistance in haematology patients.

P2860

Q26825326-FAB5B2B7-CBAC-4C73-9EE3-E6E1C0D931D6 Q38613929-687403FF-86C0-400D-883B-29D75CB60423

P2860

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

http://www.wikidata.org/entity/Q37463209

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

@en

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

@nl

type

label

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

@en

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

@nl

prefLabel

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

@en

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

@nl

P1433

Q37463209-CDFA937F-6AA2-4BE5-A742-694AF831AAAB

P1476

Q37463209-22F07B75-B2CF-4249-AFCA-1D90EA935CF0

P2093

Q37463209-3AF123CE-1AC7-4D32-BCAD-07EB91293EF1

Q37463209-A911AB94-ABE5-477D-8A93-3276865EA42B

P2860

Q37463209-1ACBE080-0450-4488-AC3C-023E5C64F63B

Q37463209-26E14914-12EA-476D-91FB-DC75FCF1A8E4

Q37463209-2F17E8EF-500F-4BA3-9372-39A62B81435F

Q37463209-40C20734-2E92-4335-B089-D5A1FA119CEF

Q37463209-45888F1D-D398-4366-ADCB-51E749482CF3

Q37463209-55D16ED8-901F-46E6-84E8-FB3422AE4BD2

Q37463209-66F6256B-1592-4F49-A9DE-8313A71EC4EE

Q37463209-6DD19824-CC83-4B06-8375-F5F2D2F5E60D

Q37463209-6E2AF883-393C-4C04-BEB2-160E2331EB9E

Q37463209-6E551866-9837-4A71-B686-B03A7806B402

P304

Q37463209-DCD54FB2-C96C-4A90-8F6E-774829014BB3

P31

Q37463209-A2B8DD6D-B8C2-4F7F-AA0F-9CFC7EDD9EE0

P356

Q37463209-35678BAC-6F8F-4C12-BFBB-F26C2DD7B137

P433

Q37463209-E9725C95-6165-4E3A-8FD8-C2C30CF906DC

P478

Q37463209-AC35A6A1-B6BE-420A-85B2-DE2BFE1C76DC

P50

Q37463209-2DE70439-9B37-4E6E-8EAB-CB616DE9E8A7

Q37463209-67201DED-460B-43FD-AD35-90B20EE02EE0

P577

Q37463209-375D39A3-D3D3-412E-BE5C-85D84190D170

P698

Q37463209-4A43A4E9-3DF2-4FD1-B6A0-2A5F5E34A1FB

P356

P1433

Expert Review of Anti-infective Therapy

P1476

Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?

@en

P2093

Christos Christodoulou

http://www.w3.org/2001/XMLSchema#string

Vasilios D Kouranos

http://www.w3.org/2001/XMLSchema#string

P2860

Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials.

Prospective, randomized study comparing quinupristin-dalfopristin with linezolid in the treatment of vancomycin-resistant Enterococcus faecium infections.

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence.

Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate.

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.

Oxazolidinones: a new class of antibacterials.

Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.

Linezolid for the treatment of adults with bone and joint infections.

P304

415-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERI.09.11

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Matthew E. Falagas

Petros I Rafailidis

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19400761

http://www.w3.org/2001/XMLSchema#string